Question follow-through · 13849

Nirmatrelvir/ritonavir

To ask the Secretary of State for Health and Social Care, if he will have discussions with NICE on the potential merits of offering Paxlovid to people over the age of 50.

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body: Department of Health and Social Care
Tabled: 12 Nov 2024
Target answer date: 14 Nov 2024
Answer: 19 Nov 2024 · 7 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

Votes on this topic

Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
Health Bill: Report Stage: New Clause 143 · 8 Sept 2026

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

12 Nov 2024
Question tabled
To ask the Secretary of State for Health and Social Care, if he will have discussions with NICE on the potential merits of offering Paxlovid to people over the age of 50.
14 Nov 2024
Target answer date
Date supplied by the official written-questions record.
19 Nov 2024
Answer published
Decisions on whether licensed medicines should be recommended for routine National Health Service funding are made independently by the National Institute for Health and Care Excellence (NICE), on the basis of the evidence of the costs and benefits. The D...

Open official record

Official data retrieved 27 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.